Influence on estimated glomerular filtration rate in patients with ischemic heart disease and hyperuricemia medicated by febuxostat.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Pharmacodynamics
- 17 Dec 2013 Planned End Date changed from 30 Jun 2014 to 30 Jun 2015 as reported by University Hospital Medical Information Network - Japan.
- 27 Nov 2012 New trial record